Success examples
Combining BET inhibition with SMAC mimetics restricts tumor growth and triggers immune surveillance in preclinical cancer models

Slavic Obradovic K., Ebner F., Artemov A. V., Miotto M., Traexler P-E., Jacob R., Thanh H. P. T., Ruzicka R., Wernitznig A., Baumann I., Gerlach D., Impagnatiello M-A., Siena S., Murphy M., House R., Reiser U., Santoro V., Popow J., Carotta S., Baum A., Lipp J., Bardelli A., Tontsch-Grunt U., Russo M., Aichinger M.

Cell Rep Med. 2025, 6(9):102313.

Success examples
A Gold-PROTAC Degrades the Oncogenic Tyrosine Kinase MERTK: Insights into the Degradome from a Steady-State System

Thomas S. R., Iellici T., Park M., Klaus E., Bileck A., Gerner C., Meier-Menches S. M., Casini A.

ACS Chem Biol. 2026, 21(1):170-186.

Success examples
FAK inhibition disrupts tumor growth, apoptosis, and transcriptional regulation in GI-NETs

Toffoli L., Ditsiou A., Triboli L., Hamm V., Moschioni E., D'Este F., Gagliano T.

Endocr Oncol. 2025, 5(1):e250052.

Success examples
Curcumin monoglucuronide protects cartilage from progressive degeneration by blocking MMP-13

Roy H. S., Kulkarni C., Neethu K. M., Babu A., Arora M., Jayamurugan G., Mandal D., Guha R., Chattopadhyay N., Ghosh D.

Arch Pharm Res. 2025, 48(7-8):765-781.

Success examples
CDK8 Inhibition Releases the Muscle Differentiation Block in Fusion-driven Alveolar Rhabdomyosarcoma

Zhang S., Engel K., Fahs A., Malone C. F., Ross K., Just M., Guedes B., Granum D., Oristian K. M., Kovach A., Alexe G., Digiovanni G., Barbar L., Bentley R., Cerda-Smith C., Le Roux O., Mendes E., Zimmerman S. P., Rees M., Roth J., Shern J. F., Wood K. C., Counter C. M., Linardic C. M., Stegmaier K.

bioRxiv. 2025, 2025.07.14.663986.

Success examples
Chemical Control of Protease Activity and Gene Expression Using a Biotin-Released Inhibitory Domain

Van Keuren A. M., Simoes C. T., Tucker C. L.

ACS Synth Biol. 2025, 14(8):3065-3077.